NCT07444970

Brief Summary

Introduction \& Background: Modern dental implantology offers solutions for patients with edentulism in the maxillary arch, where sinus pneumatization and alveolar ridge atrophy are common conditions. This often requires sinus floor elevation and bone grafting prior to implant placement. Techniques such as the lateral window approach and osteotome-mediated sinus floor elevation aim to achieve sufficient vertical bone height for successful implant placement. Autogenous bone grafts have long been considered the gold standard; however, their use is associated with limitations including donor site morbidity and graft volume loss, which has encouraged the exploration of alternative grafting materials. Sticky bone is a term used in oral surgery and implantology to describe a cohesive, moldable, and adhesive bone graft material prepared by combining particulate bone graft material (xenograft) with biological additives such as Platelet-Rich Plasma (PRP) or Platelet-Rich Fibrin (PRF). Platelet-Rich Fibrin (PRF), which is used in the present study, is an autologous leukocyte and platelet-rich fibrin matrix containing cytokines, platelets, and stem cells. PRF acts as a biodegradable scaffold that promotes microvascularization and guides epithelial cell migration. In addition, PRF may serve as a carrier for regenerative cells and allows sustained release of growth factors over a period ranging from one to four weeks, thereby enhancing the wound healing environment. Objectives: The study aims to assess the clinical efficacy of sticky bone as a bone graft material in sinus lift procedures compared with conventional xenograft materials. Methods: A randomized clinical trial will be conducted comparing two groups: one receiving sticky bone with simultaneous implant placement and another receiving xenograft with implant placement. Preoperative assessment will include Cone Beam Computed Tomography (CBCT) imaging, followed by postoperative monitoring to evaluate bone height and implant stability. Study Design: Patients fulfilling the inclusion and exclusion criteria will be recruited from the dental clinic. Written informed consent will be obtained from all participants after explanation of study procedures, potential risks, and expected benefits. Eligible patients will be randomly allocated into two equal groups using a computer-generated randomization program: Group 1 (Sticky Bone group) and Group 2 (Xenograft group). Statistical Analysis: Sample size calculation was performed using G\*Power software version 3.1.9.7. The statistical test family selected was the t-test. Based on data from a previous study, a total of 16 participants were required to achieve a study power of 80% with a significance level (alpha) of 0.05. To compensate for potential dropouts, the total sample size was increased to 18 participants (9 patients per group).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Mar 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Mar 2026Apr 2027

First Submitted

Initial submission to the registry

February 25, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 3, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

March 5, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

February 25, 2026

Last Update Submit

March 3, 2026

Conditions

Keywords

Dental implantssticky bonebone graftsinus liftPRF

Outcome Measures

Primary Outcomes (1)

  • Vertical Bone Height Gain

    The primary outcome measure will be the mean increase in vertical bone height (in millimeters) following sinus floor elevation procedures. Bone height will be assessed immediately postoperatively and at 6 months postoperatively using Cone Beam Computed Tomography (CBCT) imaging.

    Immediately postoperatively and 6 months after sinus floor elevation

Secondary Outcomes (1)

  • Implant Insertion Torque

    At the time of implant placement (during surgery)

Study Arms (2)

Sticky Bone Group

EXPERIMENTAL

In this group sticky bone is used as a bone graft material in sinus lift procedures with implant placement

Procedure: Sticky bone

Xenograft Group

ACTIVE COMPARATOR

In this group traditional xenografts in sinus lift procedures with implant placement

Procedure: traditional xenograft

Interventions

Sticky bonePROCEDURE

Sticky bone graft prepared using Platelet-Rich Fibrin (PRF) combined with xenograft material during sinus floor elevation.

Sticky Bone Group

Traditional xenografts as a bone graft material will be used during sinus floor elevation.

Xenograft Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years and older.
  • Patients presenting with residual bone height of less than 5 millimeters in the posterior maxilla requiring sinus floor elevation for dental implant placement.
  • Good oral hygiene status with absence of active periodontal disease.
  • Medically fit patients with no systemic conditions contraindicating oral surgical procedures.
  • Non-smokers.
  • Absence of acute or chronic maxillary sinusitis.

You may not qualify if:

  • Presence of uncontrolled systemic diseases (e.g., uncontrolled diabetes mellitus or severe cardiovascular diseases).
  • Immunocompromised patients.
  • History of radiation therapy to the head and neck region.
  • History of sinus surgery or sinus pathology that may interfere with sinus floor elevation procedures.
  • Presence of active infection or inflammation at the intended surgical site.
  • Use of medications known to affect bone metabolism or healing, such as bisphosphonates or long-term corticosteroid therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Lee EA. Subperiosteal Minimally Invasive Aesthetic Ridge Augmentation Technique (SMART): A New Standard for Bone Reconstruction of the Jaws. Int J Periodontics Restorative Dent. 2017 Mar/Apr;37(2):165-173. doi: 10.11607/prd.3171.

    PMID: 28196155BACKGROUND
  • Abushama AA, Alim N, AlTuraiki AM, AlQahtani TT, Alotaibi NT, AlQahtani MM, AlQahtani NM. Comparison of xenograft and allograft bone graft for oral and maxillofacial surgical preparation prior to dental implantation: A systematic review. F1000Res. 2025 Jul 22;14:718. doi: 10.12688/f1000research.163924.1. eCollection 2025.

    PMID: 40951319BACKGROUND
  • Khachatryan L, Khachatryan G, Hakobyan G, Khachatryan A. Simultaneous endoscopic endonasal sinus surgery and sinus augmentation with immediate implant placement: A retrospective clinical study of 23 patients. J Craniomaxillofac Surg. 2019 Aug;47(8):1233-1241. doi: 10.1016/j.jcms.2019.04.004. Epub 2019 Apr 19.

    PMID: 31080051BACKGROUND
  • Stern A, Green J. Sinus lift procedures: an overview of current techniques. Dent Clin North Am. 2012 Jan;56(1):219-33, x. doi: 10.1016/j.cden.2011.09.003.

    PMID: 22117952BACKGROUND
  • Sogo M, Ikebe K, Yang TC, Wada M, Maeda Y. Assessment of bone density in the posterior maxilla based on Hounsfield units to enhance the initial stability of implants. Clin Implant Dent Relat Res. 2012 May;14 Suppl 1:e183-7. doi: 10.1111/j.1708-8208.2011.00423.x. Epub 2011 Dec 16.

    PMID: 22176704BACKGROUND
  • Silva LD, de Lima VN, Faverani LP, de Mendonca MR, Okamoto R, Pellizzer EP. Maxillary sinus lift surgery-with or without graft material? A systematic review. Int J Oral Maxillofac Surg. 2016 Dec;45(12):1570-1576. doi: 10.1016/j.ijom.2016.09.023. Epub 2016 Oct 17.

    PMID: 27765427BACKGROUND
  • Starch-Jensen T, Aludden H, Hallman M, Dahlin C, Christensen AE, Mordenfeld A. A systematic review and meta-analysis of long-term studies (five or more years) assessing maxillary sinus floor augmentation. Int J Oral Maxillofac Surg. 2018 Jan;47(1):103-116. doi: 10.1016/j.ijom.2017.05.001. Epub 2017 May 22.

Study Officials

  • Mohamed Bahaa Khedr, Professor

    Oral and Maxillofacial Surgery Department Faculty of Dentistry, Fayoum University

    PRINCIPAL INVESTIGATOR
  • Shaimaa Mghawry Ibrahim, Lecturer

    Oral and Maxillofacial Surgery Department Faculty of Dentistry, Fayoum University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mohga Ahmed Abd El Aziz

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 25, 2026

First Posted

March 3, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

March 5, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share